PHILADELPHIA (WPVI) -- The FDA is investigating an alarming finding on a promising cancer therapy invented at Penn Medicine. It's being linked to rare, secondary cancers. The agency said it received ...

There's probably not a hotter area of biotechnology right now than what's known as CART therapy, in which a patient's own white blood cells are genetically engineered to attack cancer. Earlier this ...

Administering radiation therapy to multiple myeloma patients waiting for CAR T cells to be manufactured was found to be safe and undisruptive to CAR T therapy, according to a new study from ...

It may be scary, but the truth is cancers occur in our bodies all the time. One study — on the tonsils of young people — found two-thirds contained abnormalities that could lead to cancer. Obviously, ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — CD19 chimeric antigen receptor T-cell therapy led to remission, or ceased disease progression, over ...

CAR-T cell therapy has been a boon for treating blood cancers. Since the technology was first brought to the clinic, CAR-T has offered patients months or years of life after they had exhausted all ...

As cancer-killing CAR-T cells course through the body, they make occasional pit stops at the gut. What they do there — and which gut microbes they meet up with — could potentially change the prospects ...

Never in their wildest dreams dreams would immunologists from the last generation have imagined chimeric antigen receptor (CAR)-T cell therapy coming to light. The very notion of genetically ...

Saint Louis University (SLU) Radiation Therapy students Leah Mann and Lauren Hass won first and second place, respectively, in the poster competition at the Chicago Area Radiation Therapy (CART) ...